Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure

ISSN： 0114-5916

Source： Drug Safety, Vol.30, Iss.9, 2007-01, pp. : 765-781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on nesiritide for treatment of decompensated heart failure

By Hobbs R.E. Mills R.M. Young J.B.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 935-942

Informa Healthcare

Access to resources Recommend Favorite

Nesiritide: A Review of its Use in Acute Decompensated Heart Failure

By Keating G.M. Goa K.L.

Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. : 47-70

Adis International

Access to resources Recommend Favorite

Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart Failure

Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Nesiritide for the treatment of congestive heart failure

By Iyengar Srinivas Feldman David S Trupp Robin Abraham William T

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 901-907

Informa Healthcare

Access to resources Recommend Favorite

Nesiritide Usage in Decompensated Heart Failure: Cost Effectiveness and Clinical Effectiveness

Heart Drug, Vol. 5, Iss. 2, 2005-03 ,pp. : 81-88

Karger

Access to resources Recommend Favorite